122 related articles for article (PubMed ID: 10770519)
1. Evaluation of the clinical utility of cerebrospinal fluid (CSF) indices of inflammatory markers in multiple sclerosis.
McMillan SA; McDonnell GV; Douglas JP; Hawkins SA
Acta Neurol Scand; 2000 Apr; 101(4):239-43. PubMed ID: 10770519
[TBL] [Abstract][Full Text] [Related]
2. Raised CSF levels of soluble adhesion molecules across the clinical spectrum of multiple sclerosis.
McDonnell GV; McMillan SA; Douglas JP; Droogan AG; Hawkins SA
J Neuroimmunol; 1998 May; 85(2):186-92. PubMed ID: 9630167
[TBL] [Abstract][Full Text] [Related]
3. Serum soluble adhesion molecules in multiple sclerosis: raised sVCAM-1, sICAM-1 and sE-selectin in primary progressive disease.
McDonnell GV; McMillan SA; Douglas JP; Droogan AG; Hawkins SA
J Neurol; 1999 Feb; 246(2):87-92. PubMed ID: 10195402
[TBL] [Abstract][Full Text] [Related]
4. Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylprednisolone therapy.
Elovaara I; Ukkonen M; Leppäkynnäs M; Lehtimäki T; Luomala M; Peltola J; Dastidar P
Arch Neurol; 2000 Apr; 57(4):546-51. PubMed ID: 10768630
[TBL] [Abstract][Full Text] [Related]
5. Serum and cerebrospinal fluid levels of soluble adhesion molecules in multiple sclerosis: predominant intrathecal release of vascular cell adhesion molecule-1.
Droogan AG; McMillan SA; Douglas JP; Hawkins SA
J Neuroimmunol; 1996 Feb; 64(2):185-91. PubMed ID: 8632061
[TBL] [Abstract][Full Text] [Related]
6. Concentration of soluble adhesion molecules (sVCAM-1, sICAM-1 and sL-selectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous involvement.
Baraczka K; Nékám K; Pozsonyi T; Jakab L; Szongoth M; Seszták M
Neuroimmunomodulation; 2001; 9(1):49-54. PubMed ID: 11435752
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal sICAM-1 production in multiple sclerosis--correlation with triple dose Gd-DTPA MRI enhancement and IgG index.
Acar G; Idiman F; Kirkali G; Ozakbaş S; Oktay G; Cakmakçi H; Idiman E
J Neurol; 2005 Feb; 252(2):146-50. PubMed ID: 15729518
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum and CSF levels of soluble CD30 during clinical remission in multiple sclerosis.
McMillan SA; McDonnell GV; Douglas JP; Droogan AG; Hawkins SA
Neurology; 1998 Oct; 51(4):1156-60. PubMed ID: 9781547
[TBL] [Abstract][Full Text] [Related]
9. Impact of cladribine on soluble adhesion molecules in multiple sclerosis.
Mitosek-Szewczyk K; Stelmasiak Z; Bartosik-Psujek H; Belniak E
Acta Neurol Scand; 2010 Dec; 122(6):409-13. PubMed ID: 20175758
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T
PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354
[TBL] [Abstract][Full Text] [Related]
11. Serum Levels of Biomarkers of Immune Activation and Associations With Neurological Impairment in Relapsing-Remitting Multiple Sclerosis Patients During Remission.
Witkowska AM; Socha K; Kochanowicz J; Karpińska E; Jakoniuk M; Zujko ME; Wilkiel M; Borawska MH; Mariak Z
Biol Res Nurs; 2016 Jan; 18(1):113-9. PubMed ID: 25911236
[TBL] [Abstract][Full Text] [Related]
12. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
Iwanowski P; Losy J; Kramer L; Wójcicka M; Kaufman E
J Neurol Sci; 2017 Sep; 380():22-26. PubMed ID: 28870573
[TBL] [Abstract][Full Text] [Related]
13. Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings.
Trojano M; Avolio C; Simone IL; Defazio G; Manzari C; De Robertis F; Calò A; Livrea P
Neurology; 1996 Dec; 47(6):1535-41. PubMed ID: 8960741
[TBL] [Abstract][Full Text] [Related]
14. Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhage.
Polin RS; Bavbek M; Shaffrey ME; Billups K; Bogaev CA; Kassell NF; Lee KS
J Neurosurg; 1998 Oct; 89(4):559-67. PubMed ID: 9761049
[TBL] [Abstract][Full Text] [Related]
15. Relationship between cerebrospinal fluid biomarkers of inflammation and tissue damage in primary progressive multiple sclerosis.
Talbot J; Højsgaard Chow H; Mahler M; Buhelt S; Holm Hansen R; Lundell H; Vinther-Jensen T; Hellem MNN; Nielsen JE; Siebner HR; von Essen MR; Sellebjerg F
Mult Scler Relat Disord; 2022 Dec; 68():104209. PubMed ID: 36257152
[TBL] [Abstract][Full Text] [Related]
16. Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity.
Dore-Duffy P; Newman W; Balabanov R; Lisak RP; Mainolfi E; Rothlein R; Peterson M
Ann Neurol; 1995 Jan; 37(1):55-62. PubMed ID: 7529475
[TBL] [Abstract][Full Text] [Related]
17. Soluble E-selectin in the serum and cerebrospinal fluid of patients with multiple sclerosis and human T-lymphotropic virus type 1-associated myelopathy.
Tsukada N; Miyagi K; Matsuda M; Yanagisawa N
Neurology; 1995 Oct; 45(10):1914-8. PubMed ID: 7477992
[TBL] [Abstract][Full Text] [Related]
18. Correlation of soluble adhesion molecules in blood and cerebrospinal fluid with magnetic resonance imaging activity in patients with multiple sclerosis.
Rieckmann P; Altenhofen B; Riegel A; Kallmann B; Felgenhauer K
Mult Scler; 1998 Jun; 4(3):178-82. PubMed ID: 9762670
[TBL] [Abstract][Full Text] [Related]
19. Increased cerebrospinal fluid chitotriosidase index in patients with multiple sclerosis.
Verbeek MM; Notting EA; Faas B; Claessens-Linskens R; Jongen PJ
Acta Neurol Scand; 2010 May; 121(5):309-14. PubMed ID: 19925532
[TBL] [Abstract][Full Text] [Related]
20. A study of increased levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) in the cerebrospinal fluid of patients with multiple sclerosis and systemic lupus erythematosus.
Baraczka K; Pozsonyi T; Szongoth M; Nékám K; Megyeri A; Balogh Z; Jakab L
Acta Neurol Scand; 1999 Feb; 99(2):95-9. PubMed ID: 10071167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
